OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Feb 2012)
What this means for you
This application is over — abandoned 13 Feb 2012. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85057044
- Mark type
- Design + words
- Filed
- 08 Jun 2010
- Published for opposition
- 16 Nov 2010
- Abandoned
- 13 Feb 2012
- Attorney of record
- Seana Smith
Goods and services
- Class 044 — Medical, beauty and agricultural services: health care information, namely, providing information about pain management
Owner
- King Pharmaceuticals Research and Development, Inc., Cary, NC, US
- King Pharmaceuticals Research and Development, Inc., Cary, NC, US
Prosecution history
- 13 Feb 2012 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 13 Feb 2012 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Jul 2011 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2011 — SOU EXTENSION 1 GRANTED
- 30 Jun 2011 — SOU EXTENSION 1 FILED
- 30 Jun 2011 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2011 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jun 2011 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Jan 2011 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Nov 2010 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Nov 2010 — PUBLISHED FOR OPPOSITION
- 13 Oct 2010 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 13 Oct 2010 — ASSIGNED TO LIE
- 29 Sept 2010 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Sept 2010 — EXAMINER'S AMENDMENT ENTERED